Normunity

Putting Cancer's Secrets in Plain Sight

New Haven, United States · Founded 2020 · $140.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$140.0M
Last Round
$75.0M Series BJan 2025
Rounds
2

About

Normunity is a clinical-stage biotechnology company developing novel anti-cancer biologics called immune normalizers, which target untapped biology at the tumor-immune interface. Founded on research from Yale School of Medicine's Lieping Chen lab, Normunity's lead program is advancing into clinical trials following a $75M Series B in January 2025. The company is headquartered in New Haven, CT with operations in Boston, MA.

Summary

Normunity is a Biotech company based in New Haven, United States, founded in 2020. It has raised $140.0M in total across 2 rounds, most recently a $75.0M Series B round in Jan 2025. Investors include Samsara BioCapital, Enavate Sciences and Canaan Partners.

Tech & App Stack

3 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJan 2025
$75.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Normunity on Indexed.vc
<a href="https://indexed.vc/companies/normunity"><img src="https://indexed.vc/api/badge/company/normunity" alt="Normunity on Indexed.vc" width="260" height="76" /></a>